急性ST段抬高型心肌梗死院前溶栓治疗的研究进展
Research Progress of Pre-Hospital Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction
DOI: 10.12677/ACM.2021.115339, PDF,   
作者: 特日格乐：内蒙古医科大学，内蒙古 呼和浩特；周 彤*：内蒙古包钢医院，内蒙古 包头
关键词: 急性ST段抬高型心肌梗死；早期溶栓；院前救治；Acute ST-Segment Elevation Myocardial Infarction； Early Thrombolysis； Pre Hospital Treatment
摘要: 急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction, STEMI)是一种发病率高、病情变化快、致残率、致死率均较高的疾病，重视及时有效的救治，才能挽救患者的生命，并且能让患者维持较高的生活质量。目前对于STEMI，有经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)、入院后溶栓及早期院前溶栓3种再灌注治疗方法，而根据我国医疗情况及救治现状，早期院前溶栓在特定时间窗内是相对更有效的治疗。本综述重点探讨如何优化院前溶栓治疗方案，使患者实现早期有效的诊治。
Abstract: Acute ST-segment elevation myocardial infarction (STEMI) is a disease with high incidence rate, rapid change in the state of illness, disability and high mortality rate. Acute STEMI should be treated timely and effectively, so that the patient’s life can be saved and the patients’ quality of life can be maintained. At present, for STEMI, there are three reperfusion methods: percutaneous coronary intervention (PCI), thrombolysis after admission and early pre hospital thrombolysis. According to the medical situation and treatment status in China, early pre hospital thrombolysis is relatively more effective in a specific time window. This review focuses on how to optimize the pre hospital thrombolytic therapy, so that patients can get early and effective diagnosis and treatment.
文章引用：特日格乐, 周彤. 急性ST段抬高型心肌梗死院前溶栓治疗的研究进展[J]. 临床医学进展, 2021, 11(5): 2355-2360. https://doi.org/10.12677/ACM.2021.115339

参考文献

[1] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病学杂志, 2015, 43(5): 380-393.
[2] 杨艳敏, 朱俊, 谭慧琼, 梁岩, 章晏, 李建东, 等. 中国ST段抬高型急性心肌梗死临床特征及治疗现状[J]. 中华医学杂志, 2005, 85(31): 2176-2181.
[3] 颜红兵, 向定成, 刘红梅, 陈辉, 陈纪言, 陈玉国, 等. ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识[J]. 中国医学前沿杂志(电子版), 2018, 10(4): 1-10.
[4] Ibanez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, C., Bueno, H., et al. (2018) 2017 ESC Guidelines for the Management of Acute Yocardial Infarction in Patients Presenting with ST-Segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-Segment Elevation of the European Society of Cardiology (ESC). European Heart Journal, 39, 119-177. [Google Scholar] [CrossRef] [PubMed]
[5] Pu, J., Ding, S., Ge, H., Han, Y., Guo, J., Lin, R., et al. (2017) Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization after Alteplase Fibrinolysis versus Primary PCI in AcuteT-Segment-Elevation Myocardial Infarction). Circulation, 136, 1462-1473. [Google Scholar] [CrossRef] 
[6] O’Gara, P.T., Kushner, F.G., Ascheim, D.D., Casey Jr., D.E., Chung, M.K., de Lemos, J.A., et al. (2013) 2013 ACCF/ AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127, e362-e425. [Google Scholar] [CrossRef] 
[7] 廖家宝, 曹文伟. 院前急救措施应用于急性心肌梗塞患者中的临床效果[J]. 临床医学研究与实践, 2020, 5(28): 55-56.
[8] Madan, M., Halvorsen, S., Di Mario, C., Tan, M., Westerhout, C.M., Cantor, W.J., et al. (2015) Relationship between Time to Invasive Assessment and Clinical Outcomes of Patients Undergoing an Early Invasive Strategy after Fibrinolysis for T-Segment Elevation Myocardial Infarction: A Patientlevel Analysis of the Randomized Early Routine Invasive Clinical Trials. JACC: Cardiovascular Interventions, 8, 166-174. [Google Scholar] [CrossRef] [PubMed]
[9] 段天兵, 向定成, 秦伟毅, 彭膺, 李如成, 彭华, 等. 建立区域协同救治网络对首诊于非冠状动脉介入治疗医院的急性心肌梗死患者再灌注时间及近期预后的影响[J]. 中华心血管病杂志, 2014, 42(8): 641-645.
[10] 国家卫生计生委合理用药专家委员会, 中国药师协会. 急性ST段抬高型心肌梗死溶栓治疗的合理用药指南(第2版) [J]. 中国医学前沿杂志(电子版), 2019, 11(1): 40-65.
[11] 陈金良, 傅向华, 马宁, 李显平, 刘保国, 柴锡庆. 溶栓前肝素治疗对急性心肌梗死后左室重构的影响[J]. 中国危重病急救医学, 2001, 13(3): 164-166.
[12] 苏昱润, 彭瑜, 白明, 张钲. 急性冠状动脉综合征后双联抗血小板疗程的研究进展[J]. 中国动脉硬化杂志, 2020, 28(7): 639-644.
[13] Han, Y.L., Liu, J.N., Jing, Q.M., Ma, Y.-Y., Jiang, T.-M., Pu, K., et al. (2013) The Efficacy and Safety of Pharmacoinvasive Therapy with Prourokinase for Acute ST-Segment Elevation Myocardial Infarction Patients with Expected Long Percutaneous Coronary Intervention Delay. Cardiovascular Therapeutics, 31, 285-290. [Google Scholar] [CrossRef] [PubMed]
[14] Ahmad, A., Ziad, N., Brett, W. and Dion, S. (2020) Emergency Medical Service Delays in ST-Elevation Myocardial Infarction: A Meta-Analysis. Heart, 106, 365-373. [Google Scholar] [CrossRef] [PubMed]
[15] 中华医学会心血管病学分会, 中国生物医学工程学会心律分会, 中国医师协会循证医学专业委员会, 等. 心律失常紧急处理专家共识[J]. 中华心血管病杂志, 2013, 41(5): 363-376.
[16] Khan, A.A., Williams, T., Al-Omary, M.S., Feeney, A.L., Majeed, T., Savage, L., Stewart, P., Faddy, S., Collins, N.J., Fletcher, P. and Boyle, A. (2020) Pre-Hospital Thrombolysis for ST-Segment Elevation Myocardial Infarction in Regional Australia: Long-Term Follow up. Internal Medicine Journal, 50, 711-715. [Google Scholar] [CrossRef] [PubMed]
[17] Lynch, A., Sobuwa, S. and Castle, N. (2020) Barriers to the Implementation of Prehospital Thrombolysis in the Treatment of ST-Segment Elevation Myocardial Infarction in South Africa: An Exploratory Inquiry. African Journal of Emergency Medicine, 10, 243-248. [Google Scholar] [CrossRef] [PubMed]
[18] 刘尧, 杨艳敏, 朱俊, 谭慧琼, 梁岩, 刘力生, 等. 急性心肌梗死合并心原性休克死亡危险因素分析[J]. 中华心血管病杂志, 2010, 38(8): 695-701.
[19] Berwanger, O., Nicolau, J.C., Carvalho, A.C., Jiang, L., Goodman, S.G., Nicholls, S.J., et al. (2018) Ticagrelor vs Clopidogrel after Fibrinolytic Therapy in Patients with ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiology, 3, 391-399. [Google Scholar] [CrossRef] [PubMed]

为你推荐